Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.24.3
Consolidated Balance Sheets - USD ($)
$ in Thousands
Jun. 30, 2024
Jun. 30, 2023
Assets:    
Cash and cash equivalents $ 24,447 $ 43,104
Accounts receivable, net of allowance of $294 and $0 as of June 30, 2024 and 2023, respectively 3,911 4,753
Inventory 2,223 7,548
Investment tax credit receivable 3,197
Other current assets 2,991 4,440
Total current assets 36,769 59,845
Property and equipment, net 12,905 57,826
Goodwill 6,508 14,559
Intangibles, net 12,565 15,241
Operating lease right-of-use asset, net 923 1,374
Other assets 71 72
Total Assets 69,741 148,917
Current Liabilities:    
Accounts payable and accrued expenses 16,352 17,027
Litigation related contingent liability 57,372
Notes payable 10,000
Operating lease liability 514 439
Deferred revenue 131 105
Total current liabilities 84,369 17,571
Long-term Liabilities:    
Convertible notes payable, net 41,887 43,347
Operating lease liability 462 976
Notes payable 667
Other long-term liabilities 117 117
Total long-term liabilities 42,466 45,107
Total Liabilities 126,835 62,678
Commitments and Contingencies (Note 15)
Stockholders’ Equity (Deficit)    
Preferred Stock, par value $0.001: 5,000,000 shares authorized; none issued and outstanding
Common stock, $0.001 par value; 175,000,000 shares authorized; 123,392,181 and 72,154,647 shares issued and outstanding at June 30, 2024 and June 30, 2023, respectively 123 72
Additional paid in capital 381,289 356,522
Accumulated deficit (438,506) (270,355)
Total Stockholders’ Equity (Deficit) (57,094) 86,239
Total Liabilities and Stockholders’ Equity (Deficit) $ 69,741 $ 148,917